Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Obesity and Breast Cancer Metastasis across Genomic Subtypes.
Olsson LT, Walens A, Hamilton AM, Benefield HC, Fleming JM, Carey LA, Hursting SD, Williams KP, Troester MA. Olsson LT, et al. Among authors: fleming jm. Cancer Epidemiol Biomarkers Prev. 2022 Oct 4;31(10):1944-1951. doi: 10.1158/1055-9965.EPI-22-0013. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 35973227 Free PMC article.
Race-associated biological differences among Luminal A breast tumors.
D'Arcy M, Fleming J, Robinson WR, Kirk EL, Perou CM, Troester MA. D'Arcy M, et al. Breast Cancer Res Treat. 2015 Jul;152(2):437-48. doi: 10.1007/s10549-015-3474-4. Epub 2015 Jun 25. Breast Cancer Res Treat. 2015. PMID: 26109344 Free PMC article.
Nuclear Localized LSR: A Novel Regulator of Breast Cancer Behavior and Tumorigenesis.
Reaves DK, Hoadley KA, Fagan-Solis KD, Jima DD, Bereman M, Thorpe L, Hicks J, McDonald D, Troester MA, Perou CM, Fleming JM. Reaves DK, et al. Among authors: fleming jm. Mol Cancer Res. 2017 Feb;15(2):165-178. doi: 10.1158/1541-7786.MCR-16-0085-T. Epub 2016 Nov 17. Mol Cancer Res. 2017. PMID: 27856957 Free PMC article.
Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cells.
Oladapo HO, Tarpley M, Sauer SJ, Addo KA, Ingram SM, Strepay D, Ehe BK, Chdid L, Trinkler M, Roques JR, Darr DB, Fleming JM, Devi GR, Williams KP. Oladapo HO, et al. Among authors: fleming jm. Cancer Lett. 2017 Dec 28;411:136-149. doi: 10.1016/j.canlet.2017.09.033. Epub 2017 Sep 28. Cancer Lett. 2017. PMID: 28965853 Free PMC article.
Hepatocyte growth factor pathway expression in breast cancer by race and subtype.
Jones GS, Hoadley KA, Olsson LT, Hamilton AM, Bhattacharya A, Kirk EL, Tipaldos HJ, Fleming JM, Love MI, Nichols HB, Olshan AF, Troester MA. Jones GS, et al. Among authors: fleming jm. Breast Cancer Res. 2021 Aug 3;23(1):80. doi: 10.1186/s13058-021-01460-5. Breast Cancer Res. 2021. PMID: 34344422 Free PMC article.
Racial differences in breast cancer outcomes by hepatocyte growth factor pathway expression.
Jones GS, Hoadley KA, Benefield H, Olsson LT, Hamilton AM, Bhattacharya A, Kirk EL, Tipaldos HJ, Fleming JM, Williams KP, Love MI, Nichols HB, Olshan AF, Troester MA. Jones GS, et al. Among authors: fleming jm. Breast Cancer Res Treat. 2022 Apr;192(2):447-455. doi: 10.1007/s10549-021-06497-w. Epub 2022 Jan 16. Breast Cancer Res Treat. 2022. PMID: 35034243 Free PMC article.
86 results